Medicare currently covers GLP-1s for diabetes and other approved ailments such as obesity in conjunction with heart disease but is legally barred from covering the medication for weight loss alone
This multi-receptor mechanism distinguishes retatrutide from earlier generations of incretin-based research compounds including GLP-1 mono-agonists such as semaglutide, and dual GIP/GLP-1 agonists such as tirzepatide by introducing glucagon receptor activation as an additional metabolic axis
Pain relievers such as acetaminophen (Tylenol) or ibuprofen (Advil, Motrin) are also options
389:2221-2232, DOI: 10.1056/NEJMoa2307563 10
Any statements regarding the compound are derived from published scientific literature and have not been evaluated by the FDA
On the other hand, compounded semaglutide may contain additional ingredients such as vitamin B-12, vitamin B-6, L-carnitine, and others